Select Medical Appoints Thomas P. Mullin as New CEO, Announces Executive Leadership Changes.
ByAinvest
Tuesday, Sep 2, 2025 5:45 pm ET1min read
SEM--
The leadership transition comes as part of a broader restructuring, with John A. Saich appointed as sole President, John F. Duggan as Executive Vice President, General Counsel and Secretary, and Michael E. Tarvin transitioning to Senior Executive Vice President of Legal Services. These appointments reflect Select Medical's commitment to fostering growth and innovation within its leadership team.
The appointment of Mullin, who has held various executive leadership roles within the company, signifies a continuity in leadership while introducing new perspectives. Chernow, who has been with the company since 2002, has been instrumental in the company's growth and will now focus on strategic initiatives as Vice Chairman.
Select Medical's operations span 40 states and the District of Columbia, with a focus on critical illness recovery, rehabilitation hospitals, and outpatient clinics. The company's revenue outlook for 2025 remains at $5.3B to $5.5B, reflecting its commitment to expanding its inpatient rehabilitation services nationwide.
The new leadership team will be crucial in navigating the evolving regulatory environment and ensuring the company's continued success in providing high-quality post-acute care services.
References:
[1] https://seekingalpha.com/news/4491479-select-medical-names-new-ceo-announces-executive-leadership-changes
[2] https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-appoints-thomas-p-mullin-as-chief-executive-officer-and-announces-other-changes-involving-long-tenured-leaders-302542724.html
Select Medical Holdings has appointed Thomas P. Mullin as CEO, effective immediately. Mullin succeeds David S. Chernow, who becomes Vice Chairman of the board after serving as CEO since 2014. Mullin is a 17-year company veteran and most recently held the position of President and Chief Operating Officer.
Select Medical Holdings (NYSE: SEM) has announced significant executive changes with the appointment of Thomas P. Mullin as CEO, effective immediately. Mullin succeeds David S. Chernow, who has been promoted to Vice Chairman of the board. Mullin has been a 17-year veteran of the company and most recently served as co-president overseeing 140 hospitals in the company’s critical illness recovery and inpatient rehabilitation divisions.The leadership transition comes as part of a broader restructuring, with John A. Saich appointed as sole President, John F. Duggan as Executive Vice President, General Counsel and Secretary, and Michael E. Tarvin transitioning to Senior Executive Vice President of Legal Services. These appointments reflect Select Medical's commitment to fostering growth and innovation within its leadership team.
The appointment of Mullin, who has held various executive leadership roles within the company, signifies a continuity in leadership while introducing new perspectives. Chernow, who has been with the company since 2002, has been instrumental in the company's growth and will now focus on strategic initiatives as Vice Chairman.
Select Medical's operations span 40 states and the District of Columbia, with a focus on critical illness recovery, rehabilitation hospitals, and outpatient clinics. The company's revenue outlook for 2025 remains at $5.3B to $5.5B, reflecting its commitment to expanding its inpatient rehabilitation services nationwide.
The new leadership team will be crucial in navigating the evolving regulatory environment and ensuring the company's continued success in providing high-quality post-acute care services.
References:
[1] https://seekingalpha.com/news/4491479-select-medical-names-new-ceo-announces-executive-leadership-changes
[2] https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-appoints-thomas-p-mullin-as-chief-executive-officer-and-announces-other-changes-involving-long-tenured-leaders-302542724.html

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet